Target intelligence / Profile preview

Host intestinal microbiota and mucosal environment

Molecular classification
Other
01

Overview

The host intestinal microbiota and mucosal environment constitute a complex, multi-kingdom ecosystem residing within the gastrointestinal tract, consisting of bacteria, archaea, fungi, and viruses, alongside the host's protective mucus and epithelial layers (Nature Reviews Microbiology, 2020). This system is vital for human health, performing functions such as the fermentation of non-digestible carbohydrates into short-chain fatty acids, synthesis of vitamins K and B12, and the regulation of systemic immunity (NIH, 2023). Dysbiosis, or the disruption of this ecological balance, is a primary driver of Clostridioides difficile infection and is strongly associated with chronic conditions like inflammatory bowel disease (IBD) and obesity (Science, 2021). Therapeutic strategies targeting this environment include fecal microbiota transplantation (FMT) and live biotherapeutic products like Rebyota and Vowst, which aim to restore a healthy microbial community and reinforce the mucosal barrier (FDA, 2023). By modulating the gut-brain and gut-immune axes, these therapies represent a paradigm shift toward ecosystem-level medical interventions.

Other names
Gut microbiotaIntestinal microbiomeGastrointestinal floraMucosal nicheGut-mucosal barrier
02

Mechanism of action

Restoration of microbial diversity and ecological balance, competitive exclusion of pathogens, and modulation of host-microbe metabolic signaling such as short-chain fatty acid production.

03

Biological functions

Immune responseMetabolic homeostasisPathogen defenseIntestinal barrier maintenanceVitamin synthesisOther
04

Disease associations

InfectionInflammationCancerOther
05

Safety considerations

Transmission of infectious agentsBacteremia in immunocompromised patientsTransfer of antibiotic resistance genesUnintended systemic immune activation
06

Interacting drugs

Fecal microbiota, live-jslm

5 more in the full profile.

07

Biomarkers

Microbial alpha-diversity (Shannon index)Fecal calprotectinShort-chain fatty acid (SCFA) levelsFirmicutes-to-Bacteroidetes ratio

Beyond the preview

Go deeper on Host intestinal microbiota and mucosal environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host intestinal microbiota and mucosal environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call